Similar Articles
341 Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
342 Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
343 Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma
344 Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
345 Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
346 Hepatocellular carcinoma: State of the art diagnostic imaging
347 Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
348 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
349 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
350 Prevention of malignant digestive system tumors should focus on the control of chronic inflammation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA